None listed
Conditions
Interventions
Intervention1: Vitamin D and Calcium Supplement: Vitamin D - 1000 IU and Calcium 500 mg
1 tablet orally 6 days a week
Total duration of therapy - 180 days
Intervention2: Zinc Supplement: Zinc Sulphate - 10 mg
Total duration of therapy - 180 days
Control Intervention1: Placebo: Placebo
Total duration of therapy - 180 days
Sponsors
Hirabai Cowasji Jehangir Medical Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: 6 - 12 year old apparently healthy children
Exclusion criteria
Exclusion criteria: Children who have serious medical conditions Those who are severely anaemic (i.e. Hb < 7g/dl) Those who have received Calcium/Vitamin D/Zinc supplements previously
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in frequency and/or duration and/or severity of episodes of common infections like respiratory tract infections, gastrointestinal tract infections, skin infectionsTimepoint: Data collected by a questionnaire every fortnight | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Vitamin D, Zinc and Cathelicidin levelsTimepoint: At baseline and endline | — |
Countries
India
Contacts
Public ContactDr Ravindra Ghooi
Hirabai Cowasji Jehangir Medical Research Institute
Outcome results
None listed